JP2022551672A5 - - Google Patents
Info
- Publication number
- JP2022551672A5 JP2022551672A5 JP2022522322A JP2022522322A JP2022551672A5 JP 2022551672 A5 JP2022551672 A5 JP 2022551672A5 JP 2022522322 A JP2022522322 A JP 2022522322A JP 2022522322 A JP2022522322 A JP 2022522322A JP 2022551672 A5 JP2022551672 A5 JP 2022551672A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- breast cancer
- composition according
- effective amount
- mammary gland
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962914833P | 2019-10-14 | 2019-10-14 | |
| US62/914,833 | 2019-10-14 | ||
| PCT/US2020/055219 WO2021076444A1 (en) | 2019-10-14 | 2020-10-12 | Methods for treating breast cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022551672A JP2022551672A (ja) | 2022-12-12 |
| JP2022551672A5 true JP2022551672A5 (enExample) | 2023-09-20 |
Family
ID=75538857
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022522322A Pending JP2022551672A (ja) | 2019-10-14 | 2020-10-12 | 乳癌治療法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12582628B2 (enExample) |
| EP (1) | EP4045009A4 (enExample) |
| JP (1) | JP2022551672A (enExample) |
| CN (1) | CN114555053B (enExample) |
| AU (1) | AU2020366300A1 (enExample) |
| WO (1) | WO2021076444A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2025501657A (ja) * | 2022-01-10 | 2025-01-22 | オラテック セラピューティクス， インコーポレイティド | 膵臓がんを治療するための方法 |
| CN119744351A (zh) * | 2022-03-02 | 2025-04-01 | 欧拉泰克治疗公司 | 用于治疗患有潜能未定的克隆性造血的实体癌患者的方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2651407B1 (en) | 2010-12-15 | 2016-12-21 | Olatec Industries LLC | 3-methanesulfonylpropionitrile for treating inflammation and pain |
| PL2914264T3 (pl) * | 2012-11-02 | 2017-12-29 | Merck Patent Gmbh | Pochodna 6-okso-1,6-dihydropirydazyny do zastosowania w leczeniu raka wątrobowokomórkowego (hcc) |
| PE20170255A1 (es) * | 2014-01-24 | 2017-03-22 | Dana Farber Cancer Inst Inc | Moleculas de anticuerpo que se unen a pd-1 y usos de las mismas |
| EP3589370A4 (en) * | 2017-01-06 | 2020-11-18 | Olatec Therapeutics LLC | MULTIPLE SCLEROSIS TREATMENT METHOD |
| ES2970485T3 (es) | 2017-01-06 | 2024-05-29 | Olatec Therapeutics Llc | Composición farmacéutica para su uso en el tratamiento de enfermedades cardiovasculares |
| WO2019032672A1 (en) * | 2017-08-11 | 2019-02-14 | Olatec Therapeutics Llc | METHOD OF TREATING SCHNITZLER SYNDROME |
| CA3087865A1 (en) * | 2018-01-31 | 2019-08-08 | Olatec Therapeutics Llc | Method for preventing or treating alzheimer's disease |
| JP7229565B2 (ja) | 2018-03-21 | 2023-02-28 | オラテック セラピューティクス リミティド ライアビリティ カンパニー | メラノーマを治療するための方法 |
-
2020
- 2020-10-12 EP EP20877745.8A patent/EP4045009A4/en active Pending
- 2020-10-12 AU AU2020366300A patent/AU2020366300A1/en active Pending
- 2020-10-12 WO PCT/US2020/055219 patent/WO2021076444A1/en not_active Ceased
- 2020-10-12 JP JP2022522322A patent/JP2022551672A/ja active Pending
- 2020-10-12 CN CN202080071066.3A patent/CN114555053B/zh active Active
-
2022
- 2022-04-13 US US17/659,121 patent/US12582628B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| STOUT | Superficial spreading type of carcinoma of the stomach | |
| IL277434B2 (en) | shp2 phosphatase inhibitors and methods of using them | |
| JP2022153392A5 (enExample) | ||
| JP2022121594A5 (enExample) | ||
| JP2023500483A5 (enExample) | ||
| JP2022551672A5 (enExample) | ||
| Wrightson et al. | Primary squamous cell carcinoma of the breast presenting as a breast abscess | |
| CN110678452A (zh) | 亚精胺及其衍生物的应用 | |
| JP2024521122A5 (enExample) | ||
| WO2017177962A1 (zh) | 一种用于治疗胃癌的喹啉衍生物 | |
| JP2022547331A5 (enExample) | ||
| RU2017146346A (ru) | Комбинированная терапия pac-1 | |
| JP2023102786A5 (enExample) | ||
| Kayikçioğlu et al. | Inflammatory breast metastases of ovarian cancer: a case report | |
| Bolwell et al. | Peutz‐Jeghers syndrome with pseudoinvasion of hamartomatous polyps and multiple epithelial neoplasms | |
| CN110494131A (zh) | 精胺及其衍生物在制备抗肿瘤药物中的应用 | |
| Mohanty et al. | Pleomorphic leiomyosarcoma of the adrenal gland: case report and review of the literature | |
| JP2024510975A5 (enExample) | ||
| Hørding et al. | Stage I endometrial carcinoma: a review of 140 patients primarily treated by surgery only | |
| Yarom et al. | Sacrococcygeal chordoma with unusual metastases | |
| JP2020514345A5 (enExample) | ||
| JP2024520307A5 (enExample) | ||
| Gogescu et al. | Conserving surgery: balance between good cosmetic aspect and local disease control in incipient breast cancer | |
| JP2025508502A5 (enExample) | ||
| JP2020533368A5 (enExample) |